Our Impact
Effective mental health care needs innovative research that is embedded in the real world. On these pages you can explore the impact of the NIHR Biomedical Research Centre: Maudsley and how we are making a difference to people’s lives, today and tomorrow.
Impact stories
1-7 of 7 impact stories
Improving the treatment of depression by adding quetiapine to existing treatment
Psychosis and Mood Disorders
AVATAR - A novel digital therapy to help patients manage distressing voices
Digital Therapies
Moving through the phases of clinical trials in psilocybin research
Experimental Medicine and Novel Therapeutics
Bringing the immune system to the forefront of psychiatry
Psychosis and Mood Disorders£50M
NIHR Funding Award (2022 - 2028)
The NIHR awarded the NIHR BRC: Maudsley funding in 2022 to continue our work developing better and more targeted treatments in brain and mental health.
Wearable technology and sleep interventions to improve emotional wellbeing of shift workers
Psychosis and Mood Disorders
Cannabidiol - Developing a new treatment for psychosis
Psychosis and Mood Disorders
Preventing psychosis in young people
Psychosis and Mood Disorders500
Research Papers (2022 - present)
Over 500 publications acknowledging NIHR BRC: Maudsley infrastructure support